More articles from 05.01 - Airway pharmacology and treatment

Association between dietary fibre, microbial metabolites and airway obstruction in COPD patients and murine models
K Budden, S F Rehman, S Shukla, K Bowerman, C Donovan, H Gomez, C Alemao, L Wood, P Dennis, P Hugenholtz, P Wark, P Hansbro

European Respiratory Journal Sep 2022, 60 (suppl 66) 3289; DOI: 10.1183/13993003.congress-2022.3289
The differential synergistic injurious effect of resistive breathing on pulmonary and extra-pulmonary lung injury
D Toumpanakis, K Glynos, V Vassilakopoulou, A Chatzianastasiou, E Mizi, M Dettoraki, F Perlikos, C Magkou, A Papapetropoulos, T Vassilakopoulos

European Respiratory Journal Sep 2022, 60 (suppl 66) 3507; DOI: 10.1183/13993003.congress-2022.3507
The role of physical rehabilitation in the treatment of COPD
K Shvets, M Ostrovskyy, O Varunkiv, I Savelikhina, M Kulynych-Miskiv, G Korzh, N Korzh, K Ostrovska

European Respiratory Journal Sep 2022, 60 (suppl 66) 3494; DOI: 10.1183/13993003.congress-2022.3494
Lung inhalation-on-chip: A triple co-culture cellular platform to predict toxicity of aerosolized toxicants
A Sengupta, W Hassan, N Roldan, J Stucki, T Krebs, O Wisser, N Hobi, O T Guenat

European Respiratory Journal Sep 2022, 60 (suppl 66) 3398; DOI: 10.1183/13993003.congress-2022.3398
Small mobile stem cells multitargeted approach to alveoli in vivo regeneration
A Rahmo

European Respiratory Journal Sep 2022, 60 (suppl 66) 3377; DOI: 10.1183/13993003.congress-2022.3377
Severe asthma in obese patients: what to expect with Mepolizumab?
A Da Cunha Fonseca, D Machado, I Pascoal, I Franco, R Lima

European Respiratory Journal Sep 2022, 60 (suppl 66) 3216; DOI: 10.1183/13993003.congress-2022.3216
Characteristics of Responders to Biologics in Patients with Severe Asthma: Based on Precision Medicine Intervention in Severe Asthma (PRISM) Study
J Lee, H Kim, J Jung, M Kim, J Choi, J Moon, S Y Park, S Kim, M Yang, B Kim, J Kwon, H Park, C S Park, T Lee, S Kim, Y Nam, H Park, B Lee, H Kwon, W Song, S W Lee, Y S Cho, T Kim

European Respiratory Journal Sep 2022, 60 (suppl 66) 3383; DOI: 10.1183/13993003.congress-2022.3383
The anti-inflammatory and antifibrotic effects of a novel, pan-phosphodiesterase inhibitor in murine model of allergic asthma
K Wójcik-Pszczoła, K Pociecha, E Wyska, G Chłoń-Rzepa, H Plutecka, M Zadrożna, B Nowak, P Koczurkiewicz-Adamczyk, E Pękala, R Gosens

European Respiratory Journal Sep 2022, 60 (suppl 66) 3232; DOI: 10.1183/13993003.congress-2022.3232
Analysis of transport mechanisms of substances applied to the airways in a transparent airway model
C Cornelissen, A L Thiebes, M Dreher, S Gürzing, M Reddemann

European Respiratory Journal Sep 2022, 60 (suppl 66) 3441; DOI: 10.1183/13993003.congress-2022.3441
IMPALA-2: choice of DLCO as a primary endpoint in aPAP
B C Trapnell, D Desai, B Chowdhury

European Respiratory Journal Sep 2022, 60 (suppl 66) 3136; DOI: 10.1183/13993003.congress-2022.3136

Main menu

User menu

Search

More articles from 05.01 - Airway pharmacology and treatment

Pages

Contact us